GreenCross MS supplies hemodialysis solutions of KRW 90 billion to Boryung Pharm

Published: 2017-05-23 14:32:00

Updated: 2017-05-23 14:32:00

GreenCross Medical Science(CEO Young-Pil Kim, GreenCross MS) announced on the 19^th it signed a long-term supply agreement of supplying hemodialysis solutions for 10 years with Boryung Pharm(CEO Tae-Hong Choi).

GreenCross Medical Science is expected to supply hemodialysis solutions worth of approximately KRW 90 billion to Boryung Pharm for the next 10 years from this year to 2027. The amount is...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.